Baker Bros. Advisors LP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:21 pm Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 6,751,565 9.700% |
1,799,113 (+36.33%) |
Filing |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 4,952,452 9.990% |
150,498 (+3.13%) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 4,801,954 9.990% |
2,347,872 (+95.67%) |
Filing |
| 2022-02-14 4:15 pm Purchase |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 2,454,082 5.500% |
2,454,082 (New Position) |
Filing |